Status:
COMPLETED
Fecal Biomarker Study for Patients With Ulcerative Colitis
Lead Sponsor:
Warner Chilcott
Conditions:
Ulcerative Colitis
Eligibility:
All Genders
18+ years
Brief Summary
The present study will analyze fecal levels of FC and FL in UC patients who relapse (flare) while on a QD or a BID Asacol treatment regimen and compare those levels to levels of FC and FL in UC patien...
Eligibility Criteria
Inclusion
- Be willing and able to provide written informed consent for this biomarker study;
- Be enrolled in Study 2007021 (QDIEM).
Exclusion
- Meet the QDIEM Protocol 2007021 for Exclusion Criteria
Key Trial Info
Start Date :
August 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT00780507
Start Date
August 1 2007
End Date
July 1 2009
Last Update
May 31 2013
Active Locations (61)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Facility
Lowell, Arkansas, United States, 72745
2
Research Facility
Anaheim, California, United States, 92801
3
Research Facility
Folsom, California, United States, 95630
4
Research Facility
Los Angeles, California, United States, 90045